Nootropic Peptides

For laboratory and research use only — not for human consumption. All content is educational.

Category

Neurogenesis peptides

Peptides that drive the formation of new neurons or new synaptic connections in the adult brain, principally through growth-factor receptor pathways.

Neurogenesis

Dihexa

An orally active hexapeptide derivative of angiotensin IV, characterised in academic research as among the most potent known pro-cognitive compounds in animal models.

Read profile
Neurogenesis

FGL Peptide

A 15-amino-acid peptide mimetic of the FGL loop of the neural cell adhesion molecule (NCAM), studied for neurogenic, synaptogenic, and memory-enhancing effects in cellular and animal research.

Read profile
Neurogenesis

P21

A small peptide derived from a neurotrophic-cytokine framework, characterised in academic research for hippocampal neurogenesis induction and anti-neuroinflammatory effects in models of cognitive ageing and Alzheimer-type pathology.

Read profile
Neurogenesis

GHK-Cu (cognitive angle)

A naturally occurring tripeptide-copper complex best known for skin and tissue-repair effects, but with a distinct cognitive-research literature covering gene-expression modulation, antioxidant defence, and indirect neurotrophic effects.

Read profile
Neurogenesis

Davunetide

An 8-amino-acid ADNP-derived peptide (NAPVSIPQ) evaluated in multiple neurodegenerative disease trials — the flagship clinical-trial peptide in the synaptogenic / neuroprotective family.

Read profile
Neurogenesis

ARA-290 (Cibinetide)

An 11-amino-acid non-erythropoietic EPO analogue, studied for tissue-protective and neuroprotective effects mediated by the innate repair receptor (IRR) — a distinctive mechanism separated from EPO's erythropoietic activity.

Read profile
Neurogenesis

IGF-1 LR3

A synthetic long-acting analogue of insulin-like growth factor 1 with reduced IGF-binding-protein affinity, providing sustained systemic IGF-1 signalling with direct hippocampal-neurogenesis implications.

Read profile